Investors in Neurology

BrainDTech is focused on the early diagnosis and monitoring of neurological and neurodegenerative disorders, leveraging advanced technology and innovative research. By providing accurate and timely insights, BrainDTech aims to improve patient outcomes and quality of life. Their commitment to excellence drives the development of cutting-edge solutions in the field of neurology.

UCB Ventures is a €150 million strategic corporate venture fund. UCB is a global biopharmaceutical company focused on neurology and immunology disorders, driven by innovative science to enhance patient lives worldwide. We work closely and forge strong connections with patients, caregivers, health care professionals and other stakeholders who know the challenges of these diseases and where the unmet needs are found all too well.